GCG and obesity due to melanocortin 4 receptor deficiency: Nonetheless, OXM or itspharmacological analogues may still play a role in treating obesity, insulinresistance, and glucose intolerance (5, 6), offeringpotential benefits for a significant subset of women with PCOS who also suffer fromthese comorbidities.